English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/148374
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 2 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

AutorJover, Eva; Marín, Francisco; Quintana, Míriam; Pérez-Andréu, Joaquín; Hurtado, José Antonio; Rodríguez, Cristina; Martínez-González, José; González-Conejero, Rocío; Valdés, Mariano; Hernández-Romero, Diana
Palabras claveVascular calcification
Calumenin
Gamma-carboxylation
Vascular smooth muscle cell
rs1043550
Fecha de publicaciónmay-2015
EditorElsevier
CitaciónJournal of Molecular and Cellular Cardiology 82: 218-227 (2015)
ResumenCalumenin inhibits gamma-carboxylation of matrix-Gla-protein preventing BMP2-dependent calcification. Our aim was to explore the clinical relevance and functionality of the CALU polymorphism rs1043550, and the relationship of calumenin time-dependent expression profile with the active calcification of human vascular smooth muscle cells (hVSMC). Coronary artery calcium score and lesion severity were assessed by cardiac computed tomography in 139 consecutive low-risk patients genotyped for rs1043550. Polymorphic (G) allele carriage was associated with lower calcium (OR: 6.19, p= 0.042). Calcified arteries from CALU 'A' allele carriers undergoing cardiovascular surgery exhibited higher residual calcification, higher calumenin immunostaining and lower matrix-Gla-protein, contrary to 'G' allele carriers. In a luciferase reporter system in vascular cells, polymorphic 'G' allele reduced the mRNA stability by 30% (p<. 0.05). Osteogenic high-phosphate media induced active differentiation of hVSMC onto functional osteoblast-like cells as demonstrated by extracellular matrix mineralization and osteoblast markers expression. Calumenin was early over-expressed at day 3 (p<. 0.05), but decreased thereafter (mRNA and protein) with implications on gamma-carboxylation system. Calumenin was found released and co-localizing with extracellular matrix calcifications. The CALU polymorphism rs1043550 affects mRNA stability and tissue availability of calumenin thus supporting the protective clinical significance. Calumenin shows a time-dependent profile during induced calcification. These data demonstrate a novel association of vascular calcification with the VSMC phenotypic transition into osteoblast-like cells. Moreover, hyperphosphatemic stimuli render calumenin accumulation in the mineralized extracellular matrix. © 2015 Elsevier Ltd.
Versión del editorhttps://doi.org/10.1016/j.yjmcc.2015.03.015
URIhttp://hdl.handle.net/10261/148374
DOI10.1016/j.yjmcc.2015.03.015
Identificadoresdoi: 10.1016/j.yjmcc.2015.03.015
issn: 1095-8584
Aparece en las colecciones: (CIC) Artículos
(IIBB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.